B of A Securities Initiates Coverage On Arrowhead Pharma With Buy Rating, Announces Price Target of $29
B of A Securities Initiates Coverage On Arrowhead Pharma With Buy Rating, Announces Price Target of $29
Bof A Securities以買入評級啓動對Arrowhead Pharma的報道，宣佈目標股價爲29美元
B of A Securities analyst Jason Gerberry initiates coverage on Arrowhead Pharma (NASDAQ:ARWR) with a Buy rating and announces Price Target of $29.
Bof A Securities分析師傑森·格伯裏以買入評級開始對Arrowhead Pharma（納斯達克股票代碼：ARWR）進行報道，並宣佈目標股價爲29美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。